Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study


Cutland C. L. , Nolan T., Halperin S. A. , Kurugol Z. A. , Ahmed K., Perrett K. P. , ...More

VACCINE, vol.36, no.14, pp.1908-1916, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 14
  • Publication Date: 2018
  • Doi Number: 10.1016/j.vaccine.2018.02.013
  • Title of Journal : VACCINE
  • Page Numbers: pp.1908-1916

Abstract

Background: We evaluated the immunogenicity and safety of 1 and 2 doses of quadrivalent meningococcal serogroup A, C, W and Y tetanus toxoid-conjugate vaccine (MenACWY-IT) given alone or co administered with 13-valent pneumococcal conjugate vaccine (PCV13) in toddlers.